Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
about
Clinical applications of PD-L1 bioassays for cancer immunotherapy.Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.Immunogenomics: using genomics to personalize cancer immunotherapy.PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcoma.PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load.Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response.Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.PD-L1 as a biomarker in NSCLC: challenges and future directions.Immunohistochemistry for predictive biomarkers in non-small cell lung cancer.PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.Programmed death-ligand 1 immunohistochemistry testing for non-small cell lung cancer in practice.Beyond the Percentages of PD-L1-Positive Tumor Cells: Induced Versus Constitutive PD-L1 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma.PD-L1 immunohistochemistry for non-small cell lung carcinoma: which strategy should be adopted?PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics.Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples.PD-L1 expression testing in non-small cell lung cancer.Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD-L1.Four immunohistochemical assays to measure the PD-L1 expression in malignant pleural mesothelioma.TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma.
P2860
Q33702815-18A6789E-68D3-40DC-85BE-2756192CAAE4Q38704949-8F783FD5-A49A-4E0D-A6E7-DA15639C93E4Q38772744-5EE87609-94F4-4246-A6C9-61DE47FD4C82Q38839136-148E43F9-B751-4D21-93C6-A4EE079598EAQ38931346-123290EB-9EC4-4DE6-BE68-BBB67AB3D251Q39194722-4A27E9E8-2E26-4B29-9270-729A9BFB0B43Q40096396-CBF1E983-A03F-4865-B43F-1C3E02986084Q44442015-8D44CC29-8B16-4702-8A6A-2DC4E58A9402Q47140225-A3E9B54E-C95A-4443-8A95-EA522D6876E6Q47291286-86B5AB5D-45A3-4C65-AD02-321E53FA321FQ47406496-CBCD5434-2FA0-4D74-87FC-E2752549A246Q48190359-0ADDB257-5CA4-4956-8067-A7FE53B29022Q48289963-D50D47D5-CE9B-493A-8AF2-BCE09888C805Q48620065-97CA112F-7145-4A27-8C26-D6F9146A42CDQ49494082-96AB95B9-EE0F-4F91-80CB-F35F37F51F74Q50347895-8DFA1C2C-396F-46A9-8EBC-A968462646B5Q52584388-DF01E9F6-EB26-4FC0-AFE6-86E6F529F56CQ53682256-9E982C89-933E-4244-A283-192FFCABA44AQ55221451-A35C8A9A-B0C4-4B45-A5F8-0CA814E5CDE4Q55644910-DC5A7E09-97D9-4591-91E7-B3BC70ACC64B
P2860
Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Development of a programmed ce ...... neck squamous cell carcinoma.
@en
type
label
Development of a programmed ce ...... neck squamous cell carcinoma.
@en
prefLabel
Development of a programmed ce ...... neck squamous cell carcinoma.
@en
P2093
P2860
P1433
P1476
Development of a programmed ce ...... neck squamous cell carcinoma.
@en
P2093
Amita Mistry
Anita Midha
Constantine Sabalos
Jill Walker
John A Blake-Haskins
Keith E Steele
Marlon C Rebelatto
Nicole Schechter
Paul B Robbins
P2860
P2888
P356
10.1186/S13000-016-0545-8
P577
2016-10-08T00:00:00Z
P6179
1038000202